MacroGenics
MGNX
#8652
Rank
ยฃ0.17 B
Marketcap
ยฃ2.77
Share price
-7.73%
Change (1 day)
122.94%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ0.14 Billion

According to MacroGenics's latest financial reports the company's total liabilities are ยฃ0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ0.14 B28.8%
2024-12-31ยฃ0.11 B1.38%
2023-12-31ยฃ0.11 B0%
2022-12-31ยฃ0.11 B61.55%
2021-12-31ยฃ70.84 M16.54%
2020-12-31ยฃ60.78 M-2.64%
2019-12-31ยฃ62.43 M-11.2%
2018-12-31ยฃ70.31 M27.31%
2017-12-31ยฃ55.23 M60.31%
2016-12-31ยฃ34.45 M11.16%
2015-12-31ยฃ30.99 M-8.26%
2014-12-31ยฃ33.78 M18.91%
2013-12-31ยฃ28.41 M-25.91%
2012-12-31ยฃ38.34 M-25.65%
2011-12-31ยฃ51.57 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
ยฃ87.75 B 59,497.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ63.91 B 43,310.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ62.37 B 42,261.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ24.59 B 16,601.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ61.95 B 41,976.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ49.69 B 33,648.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ0.16 B 12.48%๐Ÿ‡บ๐Ÿ‡ธ USA